Literature DB >> 30843113

Glomerular disease patients have higher odds not to reach quality targets in chronic dialysis compared with CAKUT patients: analyses from a nationwide German paediatric dialysis registry.

Katrin Lübbe1, Eva Nüsken2, Katherine Rascher3, Gero von Gersdorff3, Heyke Cramer3, Christina Samel4, Claudia Barth5, Dieter Bach5, Lutz T Weber1, Jörg Dötsch1.   

Abstract

BACKGROUND: Paediatric dialysis patients still suffer from high morbidity rates. To improve this, quality assurance programs like the German QiNKid (Quality in Nephrology for Children)-Registry have been developed. In our study, the significance of underlying renal disease on a range of clinical and laboratory parameters impacting morbidity and mortality was analysed. Our aim was to evaluate whether or not disease-specific dialysis strategies should be considered in planning dialysis for a patient.
METHODS: Inclusion criteria were defined as follows: (1) CAKUT (congenital anomalies of the kidney and urinary tract) or glomerular disease patient, (2) < 18 years of age, (3) haemodialysis or peritoneal dialysis patient. Only measurements obtained from day 90 to 365 after the date of the first dialysis in the registry were analysed. Laboratory (serum albumin, haemoglobin, ferritin, calcium, phosphate, parathyroid hormone) and clinical parameters (height, blood pressure) were analysed using mixed effects models accounting for the correlation of repeated measures in individual patients.
RESULTS: The study cohort comprised n = 167 CAKUT and n = 55 glomerular disease patients. Glomerular disease patients had significantly higher odds of hypoalbuminemia (OR 13.90, 95% CI 1.35-159.99; p = 0.0274), anaemia (OR 3.31, 95% CI 1.22-9.13; p = 0.0197), hyperphosphatemia (OR 9.69, 95% CI 2.65-37.26; p = 0.0006) and diastolic hypertension (OR 3.38, 95% CI 1.20-9.79; p = 0.0212).
CONCLUSIONS: Glomerular disease patients might require more intensive dialysis regimens. The evaluation of hydration status should be given more attention, since conditions differing between the cohorts can be linked to overhydration. The QiNKid-Registry allows monitoring of the quality of paediatric dialysis in a nationwide cohort.

Entities:  

Keywords:  Anaemia; CAKUT; Children; Diastolic hypertension; Glomerular disease; Hyperphosphatemia; Hypoalbuminemia

Mesh:

Substances:

Year:  2019        PMID: 30843113     DOI: 10.1007/s00467-019-04218-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  35 in total

1.  Mortality risk in European children with end-stage renal disease on dialysis.

Authors:  Nicholas C Chesnaye; Franz Schaefer; Jaap W Groothoff; Marjolein Bonthuis; György Reusz; James G Heaf; Malcolm Lewis; Elisabeth Maurer; Dušan Paripović; Ilona Zagozdzon; Karlijn J van Stralen; Kitty J Jager
Journal:  Kidney Int       Date:  2016-04-13       Impact factor: 10.612

2.  Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry.

Authors:  Sevcan A Bakkaloglu; Dagmara Borzych; Il Soo Ha; Erkin Serdaroglu; Rainer Büscher; Paulina Salas; Hiren Patel; Dorota Drozdz; Karel Vondrak; Andreia Watanabe; Jorge Villagra; Onder Yavascan; Maria Valenzuela; Deborah Gipson; K H Ng; Bradley A Warady; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

3.  Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease.

Authors:  Joachim Rosenkranz; Evelyn Reichwald-Klugger; Jun Oh; Martin Turzer; Otto Mehls; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

4.  One-year mortality rates in US children with end-stage renal disease.

Authors:  Blanche M Chavers; Julia T Molony; Craig A Solid; Michelle N Rheault; Allan J Collins
Journal:  Am J Nephrol       Date:  2015-03-07       Impact factor: 3.754

5.  Cardiac calcifications are more prevalent in children receiving hemodialysis than peritoneal dialysis.

Authors:  Poyyapakkam Srivaths; Rajesh Krishnamurthy; Lori Brunner; Barbara Logan; Michael Bennett; Qing Ma; Rene VanDeVoorde; Stuart L Goldstein
Journal:  Clin Nephrol       Date:  2014-04       Impact factor: 0.975

6.  Management of anemia in children receiving chronic peritoneal dialysis.

Authors:  Dagmara Borzych-Duzalka; Yelda Bilginer; Il Soo Ha; Mustafa Bak; Lesley Rees; Francisco Cano; Reyner Loza Munarriz; Annabelle Chua; Silvia Pesle; Sevinc Emre; Agnieszka Urzykowska; Lily Quiroz; Javier Darío Ruscasso; Colin White; Lars Pape; Virginia Ramela; Nikoleta Printza; Andrea Vogel; Dafina Kuzmanovska; Eva Simkova; Dirk E Müller-Wiefel; Anja Sander; Bradley A Warady; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2013-03-07       Impact factor: 10.121

7.  Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry.

Authors:  Nicholas Chesnaye; Marjolein Bonthuis; Franz Schaefer; Jaap W Groothoff; Enrico Verrina; James G Heaf; Augustina Jankauskiene; Viktorija Lukosiene; Elena A Molchanova; Conceicao Mota; Amira Peco-Antić; Ilse-Maria Ratsch; Anna Bjerre; Dimitar L Roussinov; Alexander Sukalo; Rezan Topaloglu; Koen Van Hoeck; Ilona Zagozdzon; Kitty J Jager; Karlijn J Van Stralen
Journal:  Pediatr Nephrol       Date:  2014-07-21       Impact factor: 3.714

8.  Serum albumin and von Willebrand factor: possible markers for early detection of vascular damage in children undergoing peritoneal dialysis.

Authors:  Nuran Cetın; Nadide M Sav; Duran Karabel; Ali Yildirim; Bilal Yıldız
Journal:  Clin Invest Med       Date:  2016-09-11       Impact factor: 0.825

9.  Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease.

Authors:  Michael Boehm; Andrea Riesenhuber; Wolfgang C Winkelmayer; Klaus Arbeiter; Thomas Mueller; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2007-03-30       Impact factor: 3.714

10.  Mineral metabolism and vascular damage in children on dialysis.

Authors:  Rukshana C Shroff; Ann E Donald; Melanie P Hiorns; Alan Watson; Sally Feather; David Milford; Elizabeth A Ellins; Clare Storry; Deborah Ridout; John Deanfield; Lesley Rees
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.